Tricyclic quinoxalinedione derivatives

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/06 (2006.01) A61K 31/495 (2006.01) B28B 1/40 (2006.01) B28B 21/48 (2006.01) C07C 271/22 (2006.01) C07C 279/24 (2006.01) C07C 323/44 (2006.01)

Patent

CA 2121609

- 81 - Abstract of Disclosure: A tricyclic quinoxalinedione derivative represented by the formula 1: Image wherein X represents hydrogen, alkyl, halogen, cyano, trifluoromethyl, or nitro; R1 represents hydrogen, alkyl, cycloalkyl, or cycloalkylalkyl; G represents -CONR2- or -NR2CO-, wherein R2 represents hydrogen or alkyl; J represents an acidic group or a group which is convertible thereto in vivo; E represents an basic group or a group which is convertible thereto in vivo; Y represents a single bond, alkylene, alkenylene, substituted alkylene, or Y1-Q-Y2, wherein Y1 represents a single bond or alkylene, Y2 represents alkylene, and Q represents a heteroatom selected from oxygen or sulfur; Z represents alkylene. or a pharmaceutically acceptable salt thereof, these compounds are selective antagonists of glycine binding site of the NMDA receptor.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclic quinoxalinedione derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic quinoxalinedione derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic quinoxalinedione derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1364664

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.